Fibroblast growth factor pathway promotes glycolysis by activating LDHA and suppressing LDHB in a STAT1-dependent manner in prostate cancer
Open Access
- 19 May 2024
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 22 (1) , 1-17
Abstract
Background: The initiation of fibroblast growth factor 1 (FGF1) expression coincident with the decrease of FGF2 expression is a well-documented event in prostate cancer (PCa) progression. Lactate dehydrogenase A (LDHA) and LDHB are essential metabolic products that promote tumor growth. However, the relationship between FGF1/FGF2 and LDHA/B-mediated glycolysis in PCa progression is not reported. Thus, we aimed to explore whether FGF1/2 could regulate LDHA and LDHB to promote glycolysis and explored the involved signaling pathway in PCa progression. Methods: In vitro studies used RT‒qPCR, Western blot, CCK-8 assays, and flow cytometry to analyze gene and protein expression, cell viability, apoptosis, and cell cycle in PCa cell lines. Glycolysis was assessed by measuring glucose consumption, lactate production, and extracellular acidification rate (ECAR). For in vivo studies, a xenograft mouse model of PCa was established and treated with an FGF pathway inhibitor, and tumor growth was monitored. Results: FGF1, FGF2, and LDHA were expressed at high levels in PCa cells, while LDHB expression was low. FGF1/2 positively modulated LDHA and negatively modulated LDHB in PCa cells. The depletion of FGF1, FGF2, or LDHA reduced cell proliferation, induced cell cycle arrest, and inhibited glycolysis. LDHB overexpression showed similar inhibitory effect on PCa cells. Mechanistically, we found that FGF1/2 positively regulated STAT1 and STAT1 transcriptionally activated LDHA expression while suppressed LDHB expression. Furthermore, the treatment of an FGF pathway inhibitor suppressed PCa tumor growth in mice. Conclusion: The FGF pathway facilitates glycolysis by activating LDHA and suppressing LDHB in a STAT1-dependent manner in PCa.Keywords
Funding Information
- Guangdong Basic and Applied Basic Research Foundation (2021A1515010156, 2022A1515140134)
- Dongguan Science and Technology of Social Development Program (20211800905222)
This publication has 67 references indexed in Scilit:
- Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.2003
- Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinomaThe American Journal of Surgery, 2001
- Aberrant expression of fibroblast growth factor receptor‐1 in prostate epithelial cells allows induction of promatrilysin expression by fibroblast growth factorsInternational Journal of Cancer, 2001
- Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functionsUrology, 2000
- Promatrilysin expression is induced by fibroblast growth factors in the prostatic carcinoma cell line LNCaP but not in normal primary prostate epithelial cellsThe Prostate, 1999
- Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.1999
- Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostateThe Prostate, 1997
- Receptor Specificity of the Fibroblast Growth Factor FamilyJournal of Biological Chemistry, 1996
- Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3.Proceedings of the National Academy of Sciences, 1995
- Nucleotide Sequence of a Bovine Clone Encoding the Angiogenic Protein, Basic Fibroblast Growth FactorScience, 1986